This inventor holds 6 USPTO granted patents. Top assignees: Bayer Aktiengesellschaft, Haarmann & Reimer Gmbh. Active years: 1979-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cologne, DE (1979 - 1980)
- Berg.-Gladbach, DE (1984)
Company Filing History:
Years Active: 1979-1984
Title: The Innovative Contributions of Andreas Schulze
Introduction
Andreas Schulze is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial agents and compounds that combat fungi. With a total of six patents to his name, Schulze's work has had a considerable impact on medical science.
Latest Patents
Schulze's latest patents include innovative solutions such as "Combating fungi with novel 2-azolylmethyl-1,3-dioxolane and -dioxane." This patent focuses on a derivative of the formula that includes imidazol-1-yl or 1,2,4-triazol-1-yl. Another significant patent is titled "Antimicrobial agents and their use," which relates to pharmaceutical compositions containing an active antimicrobial compound. This invention also outlines methods for combatting mycoses using the identified pharmaceutical composition.
Career Highlights
Throughout his career, Schulze has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Haarmann & Reimer GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Schulze has collaborated with notable professionals in his field, including Klaus Sasse and Klaus Naumann. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.
Conclusion
Andreas Schulze's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
